Skip to content
10-K

Annual Report

HEMAGEN DIAGNOSTICS INC

0001445866-12-001120

← back to feed
Filed
Dec 28, 2012 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Dec 13, 2012 15.5M sh
Shares Diluted FY 2012 · Sep 30, 2012 15.5M sh
Shares Diluted FY 2012 · Sep 30, 2011 15.48M sh
Operating Cash Flow FY 2012 · Sep 30, 2012 −$358.69K
Operating Cash Flow FY 2012 · Sep 30, 2011 −$337.17K
Cash And Equivalents FY 2012 · Sep 30, 2012 $66.29K
Cash And Equivalents FY 2012 · Sep 30, 2011 $213.61K
Cash And Equivalents FY 2012 · Sep 30, 2010 $151.74K
Stockholders Equity FY 2012 · Sep 30, 2012 −$3.56M
Stockholders Equity FY 2012 · Sep 30, 2011 −$2.69M
Current Liabilities FY 2012 · Sep 30, 2012 $1.95M
Current Liabilities FY 2012 · Sep 30, 2011 $1.53M
Total Liabilities FY 2012 · Sep 30, 2012 $6M
Total Liabilities FY 2012 · Sep 30, 2011 $5.58M
Current Assets FY 2012 · Sep 30, 2012 $2.09M
Current Assets FY 2012 · Sep 30, 2011 $2.45M
Total Assets FY 2012 · Sep 30, 2012 $2.44M
Total Assets FY 2012 · Sep 30, 2011 $2.89M
Eps Diluted FY 2012 · Sep 30, 2012 −$0.06
Eps Diluted FY 2012 · Sep 30, 2011 −$0.06
Eps Basic FY 2012 · Sep 30, 2012 −$0.06
Eps Basic FY 2012 · Sep 30, 2011 −$0.06
Sga Expense FY 2012 · Sep 30, 2012 $2.01M
Sga Expense FY 2012 · Sep 30, 2011 $2.43M
Rd Expense FY 2012 · Sep 30, 2012 $44.65K
Rd Expense FY 2012 · Sep 30, 2011 $5K
Net Income FY 2012 · Sep 30, 2012 −$907.32K
Net Income FY 2012 · Sep 30, 2011 −$880.48K
Operating Income FY 2012 · Sep 30, 2012 −$437.91K
Operating Income FY 2012 · Sep 30, 2011 −$472.72K
Gross Profit FY 2012 · Sep 30, 2012 $1.61M
Gross Profit FY 2012 · Sep 30, 2011 $1.96M
Cost Of Revenue FY 2012 · Sep 30, 2012 $2.43M
Cost Of Revenue FY 2012 · Sep 30, 2011 $3.18M
Revenue FY 2012 · Sep 30, 2012 $4.04M
Revenue FY 2012 · Sep 30, 2011 $5.14M